Table 3. Inflammatory genes significantly altered with statin treatment of 22L-infected mice compared to untreated 22L-infected control mice.
Simvastatin | Pravastatin | Atorvastatin | |||
---|---|---|---|---|---|
Gene | Increased in scrapie [5] | FC† | FC | FC | Description |
Ccl2 | Yes | 2.5* | 1.5 | 1.7 | Chemokine (C-C motif) ligand 2 |
Cxcl11 | Yes | 1.6 | −2.1* | −1.1 | Chemokine (C-X-C motif) ligand 11 |
Cxcl13 | Yes | 2.3* | 2.0* | 1.6 | Chemokine (C-X-C motif) ligand 13 |
Cxcr3 | Yes | −1.6 | −1.9 | −4.0* | Chemokine (C-X-C motif) receptor 3 |
Cxcr5 | Yes | 1.1 | −2.7* | −1.8 | Chemokine (C-X-C motif) receptor 5 |
Osm | Yes | −1.1 | −4.3* | −1.5 | Oncostatin M |
Tnf | Yes | 1.2 | −2.5* | −1.5 | Tumour necrosis factor |
Csf3 | No | 1.2 | −2.7*** | −1.2 | Colony stimulating factor 3 |
Il3 | No | −1.1 | −2.8* | −1.8 | Interleukin 3 |
Tnfsf4 | No | 1.1 | −2.3* | −1.5 | Tumour necrosis factor superfamily, member 4 |
Bold numerals represent significant changes that met our criteria of a minimum twofold change.
Underlined bold numerals are changes where treatment increased chemokine expression.
†Fold change in gene expression in infected statin-treated versus infected untreated mice.
* P value ≤ 0.05, ***P value ≤0.001.